Julia Wolf

Progression characteristics of the European Friedreich’s Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study

Kathrin Reetz, Imis Dogan, R.-D Hilgers et al. · The Lancet Neurology · 2016 · 150 citations

Neurodegenerative Diseases, Neurobiology Of Disease, Progression Characteristics +11

Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier

Tobias Bonifert, Kathrin N. Karle, Felix Tonagel et al. · Brain · 2014 · 77 citations · Full text

Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associated increased infection‐related toxicity

Toby A. Eyre, Amy A. Kirkwood, Julia Wolf et al. · British Journal of Haematology · 2019 · 64 citations · Full text

Impact of intended and relative dose intensity of R‐CHOP in a large, consecutive cohort of elderly diffuse large B‐cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age

Toby A. Eyre, Nicolás Martínez‐Calle, Catherine Hildyard et al. · Journal of Internal Medicine · 2019 · 39 citations · Full text

Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP

Toby A. Eyre, William Wilson, Amy A. Kirkwood et al. · Blood Advances · 2021 · 24 citations · Full text